Hepatocyte steatosis increases the expression of adhesion molecules in endothelial cells

1. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007; 25: 883-9.10.1111/j.1365-2036.2007.03246.xSearch in Google Scholar

2. Adams LA, Angulo P. Recent concepts in nonalcoholic fatty liver disease. Diabet Med. 2005; 22: 1129-33.10.1111/j.1464-5491.2005.01748.xSearch in Google Scholar

3. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005; 43: 508-14.10.1016/j.jhep.2005.02.042Open DOISearch in Google Scholar

4. Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of nonobese Asian subjects. Atherosclerosis. 2009; 203: 581-6.10.1016/j.atherosclerosis.2008.07.024Search in Google Scholar

5. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005; 54: 3541-6.10.2337/diabetes.54.12.3541Open DOISearch in Google Scholar

6. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006; 44: 865-73.10.1002/hep.21327Open DOISearch in Google Scholar

7. Targher G, Bertolini L, Scala L, Zenari L, Lippi G, Franchini M, et al. Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis. Diabetes Care. 2007; 30: e31-2.10.2337/dc07-0109Search in Google Scholar

8. Picardi A, Vespasiani-Gentilucci U. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass. Am J Gastroenterol. 2008; 103: 3036-8.10.1111/j.1572-0241.2008.02196.xSearch in Google Scholar

9. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007; 191: 235-40.10.1016/j.atherosclerosis.2006.08.021Search in Google Scholar

10. Okui H, Hamasaki S, Ishida S, Kataoka T, Orihara K, Fukudome T, et al. Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides. Int J Cardiol. 2007; 126: 53-61.10.1016/j.ijcard.2007.03.116Search in Google Scholar

11. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994; 24: 1591-601.10.1016/0735-1097(94)90162-7Search in Google Scholar

12. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000; 101: 1372-8.10.1161/01.CIR.101.12.1372Search in Google Scholar

13. Mazzone GL, Rigato I, Ostrow JD, Bossi F, Bortoluzzi A, Sukowati CH, et al. Bilirubin inhibits the TNFalpharelated induction of three endothelial adhesion molecules. Biochem Biophys Res Commun. 2009; 386: 338-44.10.1016/j.bbrc.2009.06.029Search in Google Scholar

14. Jin X, Yang YD, Chen K, Lv ZY, Zheng L, Liu YP, et al. HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD. J Hepatol. 2009; 50: 1019-28.10.1016/j.jhep.2008.10.034Search in Google Scholar

15. Kralisch S, Sommer G, Stangl V, Köhler U, Kratzsch J, Stepan H, et al. Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis. 2008; 196: 523-31.10.1016/j.atherosclerosis.2007.05.016Search in Google Scholar

16. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc. 2000; 59: 359-71.10.1017/S0029665100000410Search in Google Scholar

17. Yamawaki H, Hara N, Okada M, Hara Y.Visfatin causes endothelium-dependent relaxation in isolated blood vessels. Biochem Biophys Res Commun. 2009; 383: 503-8.10.1016/j.bbrc.2009.04.074Search in Google Scholar

18. Woo SH, Park MJ, An S, Lee HC, Jin HO, Lee SJ, et al. Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF- and VEGF-induced proliferation of human endothelial cells. J Cell Biochem. 2005; 95: 120-30.10.1002/jcb.20329Search in Google Scholar

19. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Jr Gotto AM, et al. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease patients: the Atherosclerosis Risk in Communities Study (ARIC). Circulation. 1997; 96: 4219-25.10.1161/01.CIR.96.12.4219Search in Google Scholar

20. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993; 171: 223-9.10.1002/path.1711710311Search in Google Scholar

21. O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular experssion of E-selectin, intercellular adhesion molecule-1 in human atheroscleorsis and their relation to intimal leukocyte content. Circulation. 1996; 93: 672-82.10.1161/01.CIR.93.4.672Search in Google Scholar

22. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001; 104: 1336-42.10.1161/hc3701.095949Search in Google Scholar

23. Ivan L, Antohe F. Hyperlipidemia induces endothelialderived foam cells in culture. J Recept Signal Transduct Res. 2010; 30: 106-14.10.3109/10799891003630606Search in Google Scholar

24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801-9.10.1038/362801a0Search in Google Scholar

25. Fan JG. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. J Dig Dis. 2008; 9: 63-7.10.1111/j.1751-2980.2008.00323.xSearch in Google Scholar

26. Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008; 27: 412-21.10.1111/j.1365-2036.2007.03586.xSearch in Google Scholar

27. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2007; 2: 481-5.10.1038/nprot.2007.54Open DOISearch in Google Scholar